Health Care & Life Sciences » Pharmaceuticals | Roopa Industries Ltd.

Roopa Industries Ltd. | Cash Flow

Fiscal year is April-March. All values INR Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
3,023.00
19,463.00
1,770.40
2,644.20
4,466.40
4,410.30
Depreciation, Depletion & Amortization
5,671.00
5,902.00
5,281.10
5,199.20
5,118.70
5,247.80
Other Funds
571.00
7,753.00
3,627.80
3,257.60
5,775.60
1,911.10
Funds from Operations
6,966.00
14,080.00
8,482.70
7,843.40
9,015.00
7,747
Changes in Working Capital
18,993.00
8,856.00
15,290.50
8,789.70
39,288.30
30,731.40
Net Operating Cash Flow
12,027.00
5,224.00
6,807.80
946.30
30,273.20
22,984.40
Capital Expenditures
7,672.00
2,788.00
1,561.00
-
3,890.20
Sale of Fixed Assets & Businesses
278.00
35.00
-
1,817.00
240.00
Purchase/Sale of Investments
-
-
356.90
-
-
Net Investing Cash Flow
7,394.00
2,753.00
1,917.90
1,817.00
3,650.20
Issuance/Reduction of Debt, Net
10,002.00
15,877.00
5,879.90
3,530.60
27,945.50
Net Financing Cash Flow
12,817.00
8,124.00
9,507.70
273.00
33,721.10
Net Change in Cash
6,604.00
147.00
782.00
597.70
202.40
Free Cash Flow
19,699.00
8,012.00
8,368.80
-
34,163.40
Change in Capital Stock
3,386.00
-
-
-
-

About Roopa Industries

View Profile
Address
6-2-1012, 3rd floor, TGV Mansion
Hyderabad TS 500004
India
Employees -
Website http://www.roopaindustries.com
Updated 07/08/2019
Roopa Industries Ltd. manufactures pharmaceutical products. It operates under the Manufacturing and Marketing of bulk drugs and intermediaries segment. Its products include triphenyl phosphine, glucosamine, bromine and its derivatives, esomeprazole magnesium trihydrate, and tamsulosin.